Cloud-connected Blood Pressure Monitoring for Postpartum Hypertension
This observational study is looking at how a special blood pressure (BP) cuff, connected to the cloud, can help women with high blood pressure (hypertensive disorders) after giving birth. These conditions, like preeclampsia, can be serious for new mothers. The study wants to see how well this connected BP cuff helps track your blood pressure during the first six weeks after delivery. It's for women aged 18-54 who are pregnant with a hypertensive disorder, speak English, have Medicaid, and are delivering at Prisma Health Richland. The goal is to understand if this technology can improve care for new mothers.
- Study design
- This is an observational study planning to include 540 participants. It is not testing a new drug but rather observing the use of a specific device.
- What's involved
- You would use a cloud-connected blood pressure cuff. Alerts are triggered if you haven't checked your BP for 3 days or if readings are outside a certain range.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your blood pressure will be tracked for the first six weeks postpartum.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Use of a Cloud-connected Remote Blood Pressure Monitoring Program During the Postpartum Period for Hypertensive Women
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Blood pressure ascertainmentFirst 6 weeks postpartum
BP ascertainment i.e., percent of patients submitting at least one BP value, the average number of unique BP measures per patient during the first six-weeks postpartum, and percent of patients continuing the program beyond 3 weeks postpartum.